Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pulmagen Therapeutics Ltd.
DescriptionOral, small molecule prostaglandin D2 (PGD2) receptor (CRTH2) antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2) (CRTH2) (GPR44) (DP2) (CD294)
Mechanism of ActionProstaglandin D2 (PGD2) receptor subtype DP2 (CRTH2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today